- Home
- OFAL vs RENB Comparison
OFAL vs RENB Comparison
Compare OFAL & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFAL
- RENB
- Stock Information
- Founded
- OFAL 2013
- RENB 2011
- Country
- OFAL Hong Kong
- RENB United States
- Employees
- OFAL N/A
- RENB N/A
- Industry
- OFAL Military/Government/Technical
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- OFAL Consumer Discretionary
- RENB Health Care
- Exchange
- OFAL Nasdaq
- RENB Nasdaq
- Market Cap
- OFAL 62.1M
- RENB 56.2M
- IPO Year
- OFAL 2025
- RENB N/A
- Fundamental
- Price
- OFAL $5.06
- RENB $0.29
- Analyst Decision
- OFAL
- RENB
- Analyst Count
- OFAL 0
- RENB 0
- Target Price
- OFAL N/A
- RENB N/A
- AVG Volume (30 Days)
- OFAL 2.6M
- RENB 5.3M
- Earning Date
- OFAL 01-01-0001
- RENB 05-15-2025
- Dividend Yield
- OFAL N/A
- RENB N/A
- EPS Growth
- OFAL N/A
- RENB N/A
- EPS
- OFAL N/A
- RENB N/A
- Revenue
- OFAL $386,355.00
- RENB N/A
- Revenue This Year
- OFAL N/A
- RENB N/A
- Revenue Next Year
- OFAL N/A
- RENB N/A
- P/E Ratio
- OFAL N/A
- RENB N/A
- Revenue Growth
- OFAL N/A
- RENB N/A
- 52 Week Low
- OFAL $3.75
- RENB $0.27
- 52 Week High
- OFAL $9.79
- RENB $2.34
- Technical
- Relative Strength Index (RSI)
- OFAL N/A
- RENB 36.71
- Support Level
- OFAL N/A
- RENB $0.30
- Resistance Level
- OFAL N/A
- RENB $0.33
- Average True Range (ATR)
- OFAL 0.00
- RENB 0.06
- MACD
- OFAL 0.00
- RENB 0.01
- Stochastic Oscillator
- OFAL 0.00
- RENB 6.43
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.